Assisted Ventilation Clinic Helps ALS Patient Maintain His Quality of Life
‘Every day is a good day’: a meaningful doctor-patient relationship that changed everything.
‘Every day is a good day’: a meaningful doctor-patient relationship that changed everything.
“We know that we’re here for a greater good”
Dr. Stephen Goutman joined the U-M Hockey Radio Show this week to discuss ALS patient care and the recent progress made to slow ALS.
The AAAS honored Dr. Feldman for her distinguished contributions to neuroscience and neurology, particularly through leadership, mentoring, and basic and clinical research, leading to new disease therapies and important clinical guidelines.
Quinn and his friends started the ALS Ice Bucket Challenge in 2014. Driven by social media, the campaign has raised more than $200 million for ALS research.
Research Assistant Professor Lisa McGinley, Ph.D., is directing stem cell therapy research that will provide a desperately needed treatment for Alzheimer's disease patients.
Congratulations to the Nesvizhskii Lab's "Team MSFragger Swagger."
Dr. Eva Feldman shares a message for the annual World Diabetes Day. She talks about two new diabetes centers at Michigan Medicine and the ongoing fight against COVID-19's deadly affect on those afflicted with the disease.
Michigan Medicine neurologists care for ALS patients at both the Pranger ALS Clinic and the VA Ann Arbor ALS Clinic. ALS was established as a service-connected condition in 2008.
An open label extension shows additional benefit from a drug currently being tested for patients with Lou Gehrig’s disease.
Dr. Eva Feldman gave a "Wheelhouse Talk" at Grand Valley State University's Hauenstein Presidential Studies Center, where she shared life lessons from her own personal and professional experiences as a Michigan Medicine clinician scientist.
Research Assistant Professor Benjamin Murdock, PhD, is leading research to repurpose a drug that suppresses the immune system for use in treating amyotrophic lateral sclerosis (ALS).
Doctors have observed obesity significantly increased the threat of severe and sometimes deadly coronavirus-related complications.
Positive clinical trial points to a possible additional option for patients with ALS. Dr. Stephen Goutman explains the excitement and the caution.
The 2020 Wolfe Neuropathy Research Prize honors an outstanding investigator who identifies a new cause or treatment of neuropathy. Dr. Brian Callaghan was recognized for his work with obesity and neuropathy.
In a study led by Dr. Rodica Pop-Busui, NeuroNetwork for Emerging Therapies faculty member, preliminary observations of COVID-19 patients with diabetes inspired an algorithm for glucose monitoring that’s suspected to help combat the virus’ serious complications.
A new grant will allow Dr. Matthias Kretzler and his team to study the potential of a class of therapeutics to treat kidney cells in COVID-19 patients.
Strategies to reduce severe diabetic foot infections and complications during epidemics (STRIDE)
Researchers found many instances of respiratory failure and kidney injury, but not heart failure, among COVID-19 patients admitted to ICUs across the country.
In addition to his diabetes research, Dr. Callaghan seeks to improve the efficiency in neurologic testing. Here he examined how a change to Medicare's nerve conduction study reimbursement policy in 2013 has affected the utilization, payments and patient access to the the procedure, which measures the speed at which an electrical impulse moves